CIK 1744967
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
Firm-level facts as reported by the adviser on Form ADV Part 1A (latest filing 2026-06-26). Regulatory assets under management (RAUM) is Form ADV's gross figure and can differ from a 13F long book — it includes private-fund assets, leverage and non-13(f) securities. Titles and figures as-filed. Latest ADV filing 2026-06-26. Form ADV ↗
| Name | Title (as filed) | Since | Ownership |
|---|---|---|---|
| AKKARAJU, SRINIVAS | MANAGER OF SAMSARA BIOCAPITAL, LLC | 2016-09 | 75%+ ·◆ |
| DYBBS, MICHAEL, PHILIP | PARTNER | 2017-02 | <5% ·◆ |
| DOMINGUEZ, PATRICK, MICHAEL | CHIEF COMPLIANCE OFFICER | 2026-06 | <5% |
Direct owners and executive officers as filed on the adviser's Form ADV Schedule A (as-filed titles; ADV updates annually and on material change). This lists officers and 5%+ owners — not necessarily the full portfolio-management team.
Signed this manager's latest 13F (2026-Q1). The filing's authorized signatory — frequently a compliance officer, general counsel, or CFO — not necessarily the portfolio manager or firm leadership.
| Name | Role (as filed) | Departed after | Now at (if tracked) |
|---|---|---|---|
| HUSSAIN, ABRAR, AHMED | GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER | 2024-03 | — not seen at a tracked firm |
| AHMAD, MIRAN, NASRUDDIN | CHIEF FINANCIAL OFFICER | 2024-03 | — not seen at a tracked firm |
| VAN DOREN, RICHARD, D. | CFO AND CCO | 2022-04 | — not seen at a tracked firm |
Named owners/officers on a past Form ADV Schedule A who are gone from the firm's latest filing. “Departed after” is the last dated filing they appear on. A landing shows only when the destination is another SEC-registered adviser we track.
